Machado, I.; Nieto Morales, M.G.; Cruz, J.; Lavernia, J.; Giner, F.; Navarro, S.; Ferrandez, A.; Llombart-Bosch, A.
Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome. Int. J. Mol. Sci. 2021, 22, 9423.
https://doi.org/10.3390/ijms22179423
AMA Style
Machado I, Nieto Morales MG, Cruz J, Lavernia J, Giner F, Navarro S, Ferrandez A, Llombart-Bosch A.
Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome. International Journal of Molecular Sciences. 2021; 22(17):9423.
https://doi.org/10.3390/ijms22179423
Chicago/Turabian Style
Machado, Isidro, MarÃa Gema Nieto Morales, Julia Cruz, Javier Lavernia, Francisco Giner, Samuel Navarro, Antonio Ferrandez, and Antonio Llombart-Bosch.
2021. "Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome" International Journal of Molecular Sciences 22, no. 17: 9423.
https://doi.org/10.3390/ijms22179423
APA Style
Machado, I., Nieto Morales, M. G., Cruz, J., Lavernia, J., Giner, F., Navarro, S., Ferrandez, A., & Llombart-Bosch, A.
(2021). Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome. International Journal of Molecular Sciences, 22(17), 9423.
https://doi.org/10.3390/ijms22179423